Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Date:

October 24, 2024

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings that showed enough cash on its balance sheet to fund key clinical trials.

Source link

Cafeteria raises $3M to connect brands with their most opinionated customers: teens

Nobel Laureate Bob Dylan accidentally visited the world’s largest publishing trade fair.

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Recent posts

Bitcoin is trading at record high near $85,000. Is it a good time to buy?

Kamala Harris backs smaller rise in capital-gains taxes than proposed by Biden

Baxter to sell its kidney-care business in a $3.8 billion deal to Carlyle Group

The AI ‘bubble’ has helped the U.S. stock market dominate the world. What happens if it bursts?

Rivian’s stock rockets 41% higher on $1 billion Volkswagen investment, planned JV

Worries about deficit spending after election bog down U.S. government debt

Oil prices higher after cooler U.S. inflation data

Airbnb’s stock is on pace for its biggest percentage drop ever. Here’s how some analysts think the company can rebound.

Harris sees ‘next generation of breakthroughs’ built by U.S. workers. AI, crypto could benefit.

Marriage proposals are still falling but should bottom this year, Signet says

U.S. household energy bills won’t shock consumers this winter

Oil prices rise over 3% as Israel weighs response to Iran missile attack

Two Magnificent Seven companies report this week. Only one will likely be among the biggest profit drivers.

The Fed is likely to cut interest rates until next summer as the threat of inflation fades

Larry Summers says the Fed and investors are ‘badly wrong’ on inflation’s path

Related articles

Here’s Larry Summers’ advice to Trump on the economy and Elon Musk

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Investors are bracing for higher-for-even-longer interest rates

Company

Follow us